Cargando…
Prednisone for patients with recurrent implantation failure: study protocol for a double-blind, multicenter, randomized, placebo-controlled trial
BACKGROUND: Recurrent implantation failure (RIF) brings great challenges to clinicians and causes deep frustration to patients. Previous data has suggested that prednisone may play a promising role in the establishment of pregnancy and help improve the pregnancy outcome in women with RIF. But there...
Autores principales: | Lu, Yao, Yan, Junhao, Liu, Jiayin, Tan, Jichun, Hong, Yan, Wei, Daimin, Chen, Zi-jiang, Sun, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430107/ https://www.ncbi.nlm.nih.gov/pubmed/32807234 http://dx.doi.org/10.1186/s13063-020-04630-6 |
Ejemplares similares
-
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
por: Gao, Xiangyang, et al.
Publicado: (2023) -
Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil
por: Holle, Dagny, et al.
Publicado: (2013) -
Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Dai, Liang, et al.
Publicado: (2016) -
Percutaneous Bioelectric Current Stimulation in the Treatment of Chronic Achilles Tendinopathy: Protocol for a Double-Blind, Placebo-Controlled Randomized Multicenter Trial
por: Schröder, Philipp, et al.
Publicado: (2022) -
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
por: Chen, Qi, et al.
Publicado: (2022)